Agilent Stock (NYSE:A)


ForecastRevenueOwnershipFinancialsChartTranscripts

Previous Close

$133.19

52W Range

$124.16 - $155.35

50D Avg

$136.13

200D Avg

$138.74

Market Cap

$38.65B

Avg Vol (3M)

$1.75M

Beta

1.07

Div Yield

$0.94 (0.70%)

A Company Profile


Agilent Technologies, Inc. provides application focused solutions to the life sciences, diagnostics, and applied chemical markets worldwide. The Life Sciences and Applied Markets segment offers liquid chromatography systems and components; liquid chromatography mass spectrometry systems; gas chromatography systems and components; gas chromatography mass spectrometry systems; inductively coupled plasma mass spectrometry instruments; atomic absorption instruments; microwave plasma-atomic emission spectrometry instruments; inductively coupled plasma optical emission spectrometry instruments; raman spectroscopy; cell analysis plate based assays; flow cytometer; real-time cell analyzer; cell imaging systems; microplate reader; laboratory software; information management and analytics; laboratory automation and robotic systems; dissolution testing; vacuum pumps, and measurement technologies. The Diagnostics and Genomics segment provides arrays for DNA mutation detection, genotyping, gene copy number determination, identification of gene rearrangements, DNA methylation profiling, gene expression profiling, next generation sequencing, target enrichment and genetic data management, and interpretation support software; and produces synthesized oligonucleotide. It also offers immunohistochemistry in situ hybridization, and hematoxylin and eosin staining and special staining; consumables, and software for quality control analysis of nucleic acid samples; and reagents for use in turbidimetry and flow cytometry, as well as develops liquid-based pharmacodiagnostics. The Agilent CrossLab segment provides GC and LC columns, sample preparation products, custom chemistries, and laboratory instrument supplies; and startup, operational, training, compliance support, software as a service, asset management, and consultation services. The company markets its products through direct sales, distributors, resellers, manufacturer's representatives, and electronic commerce. Agilent Technologies, Inc. was incorporated in 1999 and is headquartered in Santa Clara, California.

Show More

Industry

Medical - Diagnostics & Research

Sector

Healthcare

Exchange

NYSE

ADR

-

Country

US

Employees

17,400

IPO Date

Nov 18, 1999

Website

A Performance


Revenue Breakdown


Revenue Breakdown by Product/Service

Product/ServiceOct 23Oct 22Oct 21
Non-Instrumentation and Other$4.09B$3.94B$3.66B
Diagnostics and Genomics$1.41B--
Life Sciences and Applied Markets$3.86B--
Agilent CrossLab$1.57B--
Instrumentation$2.74B$2.91B$2.66B

Fiscal year ends in Oct 23 | Currency in USD

A Financial Summary


Oct 23Oct 22Oct 21
Revenue$6.83B$6.85B$6.32B
Operating Income$1.35B$1.62B$1.35B
Net Income$1.24B$1.25B$1.21B
EBITDA$1.71B$1.91B$1.76B
Basic EPS$4.22$4.19$3.98
Diluted EPS$4.19$4.18$3.94

Fiscal year ends in Oct 23 | Currency in USD

Latest Earnings Call Transcripts


Q4 24Nov 25, 24 | 4:30 PM
Q3 24Aug 21, 24 | 8:10 PM
Q2 24May 29, 24 | 8:35 PM

Peer Comparison


TickerCompany
TMOThermo Fisher Scientific Inc.
RVTYRevvity, Inc.
MTDMettler-Toledo International Inc.
GHGuardant Health, Inc.
DHRDanaher Corporation
IDXXIDEXX Laboratories, Inc.
ILMNIllumina, Inc.
CRLCharles River Laboratories International, Inc.
WATWaters Corporation